J. Revuz

发表

NF1 gene analysis focused on CpG‐rich exons in a cohort of 93 patients with neurofibromatosis type 1

D. Vidaud, E. G. Boulandet, J. Pantel, 2000, Human mutation.

Toxic epidermal necrolysis after fluvoxamine

O. Langeron, J. Revuz, P. Wolkenstein, 1993, The Lancet.

Neurological complications of neurofibromatosis type 1 in adulthood.

P. Brugières, J. Degos, J. Zeller, 1999, Brain : a journal of neurology.

Association between benign and malignant peripheral nerve sheath tumors in NF1

J. Zeller, J. Revuz, P. Wolkenstein, 2005, Neurology.

More on the frequency of segmental neurofibromatosis.

J. Zeller, J. Revuz, P. Wolkenstein, 1995, Archives of dermatology.

Renal involvement in toxic epidermal necrolysis.

J. Roujeau, J. Revuz, O. Chosidow, 1996, Journal of the American Academy of Dermatology.

Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.

K. Leroy, J. Zeller, J. Revuz, 2001, Archives of dermatology.

Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases.

A. Leplège, J. Zeller, J. Revuz, 2001, Archives of dermatology.

Psoriasis in France and Associated Risk Factors: Results of a Case-Control Study Based on a Large Community Survey

J. Roujeau, J. Grob, J. Revuz, 2008, Dermatology.

Three Novel Point Mutations in the Keratinocyte Transglutaminase (TGK) Gene in Lamellar Ichthyosis: Significance for Mutant Transcript Level, TGK Immunodetection and Activity

C. Bodemer, M. Lathrop, Y. Barrandon, 1997, European journal of human genetics : EJHG.

Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1

J. Zeller, J. Revuz, P. Wolkenstein, 2005, The British journal of dermatology.

Protein S deficiency in a patient with necrotizing cellulitis

J. Roujeau, J. Revuz, O. Chosidow, 1993, Clinical and experimental dermatology.

Internal Involvement in Localized Scleroderma

J. Roujeau, J. Revuz, A. Cosnes, 1994, Medicine.

Carbon dioxide laser for removal of multiple cutaneous neurofibromas

J. Zeller, J. Revuz, P. Wolkenstein, 2001, The British journal of dermatology.

Toxic epidermal necrolysis.

J. Revuz, P. Wolkenstein, Pierre Wolkenstein, 2000, Dermatologic clinics.

Allergic emergencies encountered by the dermatologist

J. Revuz, P. Wolkenstein, Jean Revuz, 1999, Clinical reviews in allergy & immunology.

Drug-Induced Severe Skin Reactions

J. Revuz, P. Wolkenstein, 1995, Drug safety.

Lithium gluconate 8% vs. ketoconazole 2% in the treatment of seborrhoeic dermatitis: a multicentre, randomized study

B. Dréno, J. Revuz, O. Chosidow, 2003, The British journal of dermatology.

Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities.

J. Roujeau, P. Morel, L. Dubertret, 1996, Archives of dermatology.

SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.

J. Roujeau, J. Revuz, P. Wolkenstein, 2000, The Journal of investigative dermatology.

Correlation between the pretreatment number of blisters and the time to control buUous pemphigoid with prednisone 1 mg/kg/day

J. Revuz, O. Chosidow, V. Saada, 1992, The British journal of dermatology.

Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients.

J. Zeller, J. Revuz, P. Wolkenstein, 1996, Archives of dermatology.

Creation of a Tool to Assess Adherence to Treatments for Acne

B. Dréno, J. Revuz, F. Poli, 2008, Dermatology.

Nocardia asteroides septicemia in a pemphigus patient. Successful treatment with trimethoprim-sulfamethoxazole and amikacin association.

C. Brun-Buisson, J. Roujeau, J. Revuz, 1990, Dermatologica.

Autoimmune disorders and interleukin-2 therapy: a step toward 'unanswered questions'.

J. Revuz, P. Wolkenstein, O. Chosidow, 1995, Archives of dermatology.

Letter to Dermatology

L. Thomas, A. Schindl, M. Schindl, 1999, Dermatology.

Usefulness of Systematic Ophthalmologic Investigations in Neurofibromatosis 1: A Cross-Sectional Study of 211 Patients

G. Soubrane, J. Zeller, J. Revuz, 2002, European journal of ophthalmology.

Cost evaluation of the medical management of neurofibromatosis 1: a prospective study on 201 patients

I. Durand-zaleski, J. Zeller, J. Revuz, 2000, The British journal of dermatology.

Cogan's syndrome. An unusual etiology of urticarial vasculitis.

J. Revuz, O. Chosidow, S. Fraitag, 1991, Dermatologica.

IL-2 phase II trial in metastatic melanoma: analysis of clinical and immunological parameters.

W. Fridman, T. Tursz, J. Revuz, 1992, Biotechnology therapeutics.

Living with Acne

B. Dréno, J. Revuz, F. Poli, 2007, Dermatology.

Living with acne. A study of adolescents' personal experiences.

B. Dréno, J. Revuz, F. Poli, 2007, Dermatology.

A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome.

P. Beaune, J. Roujeau, J. Revuz, 1995, Pharmacogenetics.

Vulvovaginal Involvement in Toxic Epidermal Necrolysis: A Retrospective Study of 40 Cases

J. Roujeau, J. Revuz, P. Wolkenstein, 1998, Obstetrics and gynecology.

Acne as seen by adolescents: results of questionnaire study in 852 French individuals.

B. Dréno, J. Revuz, D. Moyse, 2011, Acta dermato-venereologica.

Physiopathology of acne vulgaris: recent data, new understanding of the treatments.

B. Dréno, J. Revuz, F. Poli, 2004, European journal of dermatology : EJD.

Lack of Association between CARD15 Gene Polymorphisms and Hidradenitis Suppurativa: A Pilot Study

J. Hugot, J. Revuz, P. Wolkenstein, 2007, Dermatology.

Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine

P. Rosenzweig, G. Bianchetti, E. Espagne, 1996, European Journal of Clinical Pharmacology.

Optimising the Use of Tazarotene in Clinical Practice: Consensus Statement from the European Advisory Panel for Tazarotene (Zorac™)

J. Saurat, H. Gollnick, J. Revuz, 1999, Dermatology.

J. Roujeau, J. Revuz, P. Wolkenstein, 2005, Intensive Care Medicine.

[Emergencies in dermatology].

J. Roujeau, J. Revuz, O. Chosidow, 1990, Presse medicale.

Hyperamylasemia in toxic epidermal necrolysis.

J. Roujeau, J. Revuz, O. Chosidow, 1993, Archives of dermatology.

Retinoids 10 Years On

C. Brun-Buisson, R. Happle, H. Nakagawa, 1990 .

Vulvovaginal sequelae in toxic epidermal necrolysis.

J. Roujeau, J. Revuz, P. Wolkenstein, 1997, The Journal of reproductive medicine.

Visibility of neurofibromatosis 1 and psychiatric morbidity.

A. Leplège, J. Zeller, J. Revuz, 2003, Archives of dermatology.

Toxic epidermal necrolysis after sulfasalazine treatment of mild psoriatic arthritis: warning on the use of sulfasalazine for a new indication.

J. Roujeau, J. Revuz, P. Wolkenstein, 1995, Arthritis and rheumatism.

European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa

J. Lapins, J. Revuz, C. Zouboulis, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[Large hairy pigmented spots in neurofibromatosis type 1: an atypical form of neurofibromas].

J. Zeller, J. Revuz, P. Wolkenstein, 2001, Annales de dermatologie et de venereologie.

Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis

J. Roujeau, J. Revuz, P. Wolkenstein, 1996, The British journal of dermatology.

Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus.

J. Roujeau, J. Revuz, O. Chosidow, 1992, Journal of the American Academy of Dermatology.

Open trial of ciclosporin treatment for Stevens–Johnson syndrome and toxic epidermal necrolysis

J. Roujeau, J. Revuz, P. Wolkenstein, 2010, The British journal of dermatology.

[The French version of Skindex (Skindex-France). Adaptation and assessment of psychometric properties].

A. Leplège, J. Zeller, J. Revuz, 2003, Annales de dermatologie et de venereologie.

Combination Therapy with Clindamycin and Rifampicin for Hidradenitis Suppurativa: A Series of 116 Consecutive Patients

O. Faye, J. Revuz, P. Wolkenstein, 2009, Dermatology.

Diagnostic delay in hidradenitis suppurativa is a global problem

J. Lapins, L. French, J. Revuz, 2015, The British journal of dermatology.

Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases.

J. Roujeau, J. Revuz, O. Chosidow, 1992, Journal of the American Academy of Dermatology.

Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study

J. Roujeau, J. Revuz, P. Wolkenstein, 1997, Intensive Care Medicine.

Absence of Efficacy of Oral Isotretinoin in Hidradenitis Suppurativa: A Retrospective Study Based on Patients’ Outcome Assessment

J. Revuz, P. Wolkenstein, J. Revuz, 2008, Dermatology.

Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis.

J. Roujeau, L. Dubertret, J. Bonnetblanc, 1990, The Journal of investigative dermatology.

Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women.

J. Roujeau, J. Revuz, H. Turki, 1995, The Journal of investigative dermatology.

Treatment of bullous pemphigoid with dapsone: retrospective study of thirty-six cases.

J. Roujeau, J. Revuz, O. Chosidow, 1996, Journal of the American Academy of Dermatology.

Drug‐induced linear IgA disease: target antigens are heterogeneous

J. Roujeau, J. Revuz, P. Wolkenstein, 1997, The British journal of dermatology.

Combination Therapy with Clindamycin and Rifampicin for Hidradenitis Suppurativa: A Series of 116 Consecutive Patients

O. Faye, J. Revuz, P. Wolkenstein, 2009, Dermatology.

Bleeding: a complication of neurofibromatosis 1 tumors.

M. Mitrofanoff, J. Zeller, J. Revuz, 2001, Archives of dermatology.